In the present study, we further revealed that this gene was a favorable predictor of survival outcome and was associated with increased sensitivity to chemotherapeutic drug–induced pyroptosis in AML, which was in accordance with the previous study indicating that CASP3 activated by chemotherapeutic drugs initiated pyroptosis (Wang et al., 2017). Here, CASP3 is linked to acute myeloid leukemia.